Hepalatide ameliorated progression of nonalcoholic steatohepatitis in mice

Design and validation of a histological scoring system for nonalcoholic fatty liver disease†

David E. Kleiner, Elizabeth M. Brunt, Mark L. Van Natta et al. · Hepatology · 2005 · 10.5K citations

Nafld Activity Score, Diagnosis, Pathology +24

Pioglitazone, Vitamin E, or Placebo for Nonalcoholic Steatohepatitis

Arun J. Sanyal, Naga Chalasani, Kris V. Kowdley et al. · New England Journal of Medicine · 2010 · 3.2K citations · Full text

Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial

Brent A. Neuschwander‐Tetri, Rohit Loomba, Arun J. Sanyal et al. · The Lancet · 2014 · 2.2K citations

Hepatology, Medicine, Liver Physiology +7

Discovery of 6α-Ethyl-23(<i>S</i>)-methylcholic Acid (<i>S</i>-EMCA, INT-777) as a Potent and Selective Agonist for the TGR5 Receptor, a Novel Target for Diabesity

Roberto Pellicciari, Antimo Gioiello, Antonio Macchiarulo et al. · Journal of Medicinal Chemistry · 2009 · 249 citations · Full text

Pharmaceutical Science, Pharmaceutical Chemistry, Molecular Pharmacology +18

Unconjugated and secondary bile acid profiles in response to higher-fat, lower-carbohydrate diet and associated with related gut microbiota: A 6-month randomized controlled-feeding trial

Yi Wan, Jihong Yuan, Jie Li et al. · Clinical Nutrition · 2019 · 94 citations

Nutrition, Dysbiosis, Related Gut Microbiota +8